19 January 2026 Helyx Industries is born: a rebranding that consolidates a new three-division industrial structure
07 August 2025 Papillomavirus Screening: Self-sampling with HPV-Selfy is Effective and Well-Accepted by Women, a New Study Confirms.
14 April 2025 The innovative soul of Ulisse Biomed: the research and development that drives our future
10 September 2024 SMART GENE DESIGN - ERDF PR 2021-27 Line of action a1.2.1. Incentives to enterprises for process and organisational innovation activities - ULISSE BIOMED S.P.A.
12 June 2024 ULISSE BIOMED AND IKONISYS ANNOUNCE STRATEGIC PARTNERSHIP TO SUPPORT INNOVATION IN CANCER DIAGNOSTICS
20 February 2024 Hyris technology supports the fight against one of the world’s deadliest diseases, malaria.
15 January 2024 Hyris fulfils its integration into Ulisse Biomed to give birth to a new international group ready to make its mark in the global biotech market.
10 January 2024 Distribution agreement renewal with Biomol Laboratories, fostering the partnership in the field of personalised medicine
04 December 2023 Hyris' signed a binding agreement for a reverse take-over, leading to a new integrated entity with Ulisse Biomed
29 September 2023 Hyris' new onboarding programs support researchers and developers to launch testing kits.
02 November 2022 Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.
27 September 2022 Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine
20 September 2022 Hyris to participate in SEI 2022 in Leon, hosted by the Sociedad Española de Immunologia
08 August 2022 Hyris' new T-cell Test is finally available to EU Countries to easily map patients' cellular immunity to SARS-CoV-2
27 June 2022 Hyris presented Hyris System, its distruptive signature technology, at Analytica 2022 in Munich
20 June 2022 HPV SELFY INSERITO NEL RAPPORTO DEL GISCi SUI TEST HPV VALIDATI PER LO SCREENING DEL CARCINOMA DELLA CERVICE UTERINA
13 June 2022 A new T-cell activation assay based on Hyris technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity.
24 May 2022 ULISSE BIOMED PARTECIPA AL CONVEGNO "ADENOCARCINOMA: SCREENING O UNA DIAGNOSI PRECOCE? UNA NUOVA SFIDA DOPO UN DECENNIO DI TEST HPV"
18 May 2022 HPV SELFY: PRIMO HPV TEST DI GENOTIPIZZAZIONE COMPLETA VALIDATO PER LO SCREENING DEL CARCINOMA DEL COLLO DELL’UTERO SU CAMPIONI AUTO-PRELEVATI
21 December 2021 Hyris presented its new, disruptive T-Cell test at the international conference "A-Wish", fully embracing the Immunology sector to better fight COVID-19 and beyond.
02 December 2021 Hyris releases its new Demo to better support all prospect users of its portable and reliable molecular test for diagnosing SARS-CoV-2 into human subjects.
15 April 2021 The Canadian Olympic Committee and Canadian Paralympic Committee chose the HYRIS SYSTEM™ to effectively test Canadian National Sport Teams against Covid-19.
11 February 2021 Lallemand Health Solutions choose the Hyris System™ for their internal certification protocol
31 December 2020 Evaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detection
20 October 2020 Industry Leaders Embrace Hyris' "Virus Finder System" to Keep Operations Running and Employees Safe
30 September 2020 PFS Partner Hyris Secures UK Triumph with Canadian Government 90-Minute COVID-19 Testing Megadeal
29 April 2020 Hyris Ltd on Immunological Reviews - Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment
